Table 1.
Group Demographic and Psychosocial Measures
| Measure | Citalopram (n = 15) | Reboxetine (n = 15) | Placebo (n = 15) |
|---|---|---|---|
| Age, years | 24.8 (4.8) | 25.1 (4.2) | 25.2 (5) |
| Sex (M/F) | 7/8 | 7/8 | 7/8 |
| BDI | 2.5 (3.1) | 2.21 (2.8) | 1.2 (1.3) |
| Trait | 43 (5.5) | 32.3 (7.3) | 31.7 (4.8) |
| FCPS | 127 (13) | 138.2 (14) | 136.6 (14) |
| SHAPS | 22.5 (4.5) | 21.9 (4.7) | 20.4 (5.5) |
| BMI | 23.7 (3.6) | 21.6 (2.2) | 24 (2.8) |
| EAT | 4.7 (5) | 3 (3) | 4.5 (4.2) |
| Chocolate Craving | 6.4 (1.8) | 5.9 (2.1) | 4.7 (2) |
| Chocolate Liking | 8 (1.5) | 8.2 (1.43) | 8.3 (1.4) |
| Chocolate Frequent Eating | 1.06 (.3) | .82 (.45) | .78 (.33) |
Data are mean (SD) unless otherwise noted. One-way analyses of variance; p > .07.
BDI, Beck Depression Inventory; BMI, Body Mass Index; EAT, Eating Attitudes Test questionnaire; FCPS, Fawcett Clarke Pleasure Scale; SHAPS, Snaith-Hamilton Pleasure Scale.